{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:49:11Z","timestamp":1760028551087,"version":"3.44.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.ahj.2005.02.015","type":"journal-article","created":{"date-parts":[[2005,6,24]],"date-time":"2005-06-24T09:41:44Z","timestamp":1119606104000},"page":"1135.e11-1135.e18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Effects of abciximab and preprocedural glycemic control in diabetic patients undergoing elective coronary stenting"],"prefix":"10.1016","volume":"149","author":[{"given":"Leonardo","family":"De Luca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"De Persio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monia","family":"Minati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Iacoboni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Fedele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2005.02.015_bib1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","article-title":"Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction","volume":"339","author":"Haffner","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.02.015_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0002-9149(97)00797-2","article-title":"Comparison of factors associated with 30-day mortality after coronary artery bypass grafting in patients with versus without diabetes mellitus. Israeli Coronary Artery Bypass (ISCAB) Study Consortium","volume":"81","author":"Cohen","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2005.02.015_bib3","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0002-9149(98)00117-9","article-title":"One-year outcomes of diabetic versus nondiabetic patients with non\u2013Q-wave acute myocardial infarction treated with percutaneous transluminal coronary angioplasty","volume":"81","author":"Gowda","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2005.02.015_bib4","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1161\/01.CIR.96.8.2551","article-title":"Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty","volume":"96","author":"Barsness","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.02.015_bib5","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1161\/01.CIR.96.6.1707","article-title":"Problem of angioplasty in diabetes","volume":"96","author":"Ellis","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.02.015_bib6","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1161\/01.CIR.91.4.979","article-title":"Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty","volume":"91","author":"Stein","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.02.015_bib7","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1161\/01.CIR.96.6.1761","article-title":"Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI)","volume":"96","author":"Alderman","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.02.015_bib8","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1161\/01.CIR.94.8.1818","article-title":"Coronary angioplasty in diabetic patients: the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry","volume":"94","author":"Kip","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.02.015_bib9","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0735-1097(97)00334-3","article-title":"Predictive factors of restenosis after coronary stent placement","volume":"30","author":"Kastrati","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2005.02.015_bib10","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1067\/mhj.2000.103743","article-title":"Potent complementary clinical benefit of abciximab and stenting during percutaneous coronary revascularization in patients with diabetes mellitus: results of the EPISTENT trial","volume":"139","author":"Lincoff","year":"2000","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2005.02.015_bib11","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1161\/01.CIR.100.25.2477","article-title":"Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus. Results of the EPISTENT (Evaluation of Platelet IIb\/IIIa Inhibitor for Stenting Trial) diabetic study","volume":"100","author":"Marso","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.02.015_bib12","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1161\/01.CIR.0000018123.02672.C7","article-title":"Impact of different platelet glycoprotein IIb\/IIIa receptor inhibitors among diabetic patients undergoing percutaneous coronary intervention: Do Tirofiban and ReoPro Give Similar Efficacy Outcomes Trial (TARGET) 1-year follow-up","volume":"105","author":"Roffi","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.02.015_bib13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jacc.2003.06.019","article-title":"Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention","volume":"43","author":"Corpus","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2005.02.015_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0735-1097(02)02626-8","article-title":"Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction","volume":"41","author":"Iwakura","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl. 1","key":"10.1016\/j.ahj.2005.02.015_bib15","first-page":"5","article-title":"American College of Endocrinology Consensus Statement on guidelines for glycemic control","volume":"8","author":"Cobin","year":"2002","journal-title":"Endocr Pract"},{"key":"10.1016\/j.ahj.2005.02.015_bib16","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1161\/01.CIR.82.4.1193","article-title":"Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease: implications for patient selection","volume":"82","author":"Ellis","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.02.015_bib17","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0002-8703(03)00235-7","article-title":"Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention","volume":"146","author":"Muhlestein","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2005.02.015_bib18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2337\/diacare.22.2.233","article-title":"The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years","volume":"22","author":"Coutinho","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ahj.2005.02.015_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.322.7277.15","article-title":"Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk)","volume":"322","author":"Khaw","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.ahj.2005.02.015_bib20","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/S0735-1097(01)01555-8","article-title":"Blood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic control","volume":"38","author":"Osende","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2005.02.015_bib21","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/0735-1097(95)00496-3","article-title":"Potential mechanisms promoting restenosis in diabetic patients","volume":"27","author":"Aronson","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2005.02.015_bib22","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.2337\/diacare.27.5.1137","article-title":"Effect of diabetes on long-term mortality following contemporary percutaneous coronary intervention. Analysis of 4284 cases","volume":"27","author":"Wilson","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ahj.2005.02.015_bib23","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1161\/01.CIR.103.9.1218","article-title":"Patency of percutaneous transluminal coronary angioplasty sites at 6-month angiographic follow-up. A key determinant of survival in diabetics after coronary balloon angioplasty","volume":"103","author":"Van Belle","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.02.015_bib24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jacc.2003.10.016","article-title":"Optimization of glycemic control and restenosis prevention in diabetic patients undergoing percutaneous coronary interventions","volume":"43","author":"Kornowski","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2005.02.015_bib25","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0002-8703(03)00085-1","article-title":"Predictors of angiographic restenosis after coronary intervention in patients with diabetes mellitus","volume":"145","author":"Mazeika","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2005.02.015_bib26","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1161\/01.CIR.96.5.1454","article-title":"Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels","volume":"96","author":"Van Belle","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.02.015_bib27","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/S0735-1097(98)00467-7","article-title":"Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement","volume":"32","author":"Elezi","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2005.02.015_bib28","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0735-1097(98)00286-1","article-title":"The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation","volume":"32","author":"Abizaid","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2005.02.015_bib29","first-page":"129","article-title":"Diabetes mellitus: biological determinants of atherosclerosis and restenosis","volume":"4","author":"Marso","year":"1999","journal-title":"Semin Interv Cardiol"},{"issue":"Suppl. 1","key":"10.1016\/j.ahj.2005.02.015_bib30","first-page":"S33","article-title":"Clinical practice recommendations 2001","volume":"24","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ahj.2005.02.015_bib31","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1161\/01.CIR.100.25.2466","article-title":"Will blocking the platelet save the diabetic?","volume":"100","author":"King","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.02.015_bib32","first-page":"S20","article-title":"Targeting the use of glycoprotein IIb\/IIIa antagonists\u2014the diabetic patient","volume":"3","author":"Meier-Ewert","year":"2002","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.ahj.2005.02.015_bib33","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1161\/01.CIR.0000055653.52489.E9","article-title":"Important triad in cardiovascular medicine. Diabetes, coronary intervention, and platelet glycoprotein IIb\/IIIa receptor blockade","volume":"107","author":"Lincoff","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.02.015_bib34","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1161\/01.CIR.100.19.1977","article-title":"Attainment and maintenance of platelet inhibition through standard dosing of abciximab in diabetic and nondiabetic patients undergoing percutaneous coronary intervention","volume":"100","author":"Steinhubl","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.02.015_bib35","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJM199907293410503","article-title":"Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb\/IIIa receptors","volume":"341","author":"Lincoff","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.02.015_bib36","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1161\/01.CIR.102.20.2466","article-title":"Glycoprotein IIb\/IIIa receptor blockade improves outcomes in diabetic patients presenting with unstable angina\/non\u2013ST-elevation myocardial infarction","volume":"102","author":"Theroux","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.02.015_bib37","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1161\/hc4801.100029","article-title":"Platelet glycoprotein IIb\/IIIa inhibitors reduce mortality in diabetic patients with non\u2013ST-segment-elevation acute coronary syndromes","volume":"104","author":"Roffi","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.02.015_bib38","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0735-1097(99)00650-6","article-title":"Abciximab reduces mortality in diabetics following percutaneous coronary intervention","volume":"35","author":"Bhatt","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2005.02.015_bib39","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1161\/01.CIR.0000148956.93631.4D","article-title":"Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel","volume":"110","author":"Mehilli","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.02.015_bib40","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0002-9149(02)02567-5","article-title":"Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus","volume":"90","author":"Bhatt","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2005.02.015_bib41","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2005.02.015_bib42","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2165\/00003495-200060020-00012","article-title":"Clopidogrel: a review of its use in the prevention of atherothrombosis","volume":"60","author":"Jarvis","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.ahj.2005.02.015_bib43","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/heart.85.1.92","article-title":"Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement","volume":"85","author":"M\u00fcller","year":"2001","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2005.02.015_bib44","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1056\/NEJMoa031859","article-title":"A clinical trial of abciximab in elective percutaneous coronary inter-vention after pretreatment with clopidogrel","volume":"350","author":"Kastrati","year":"2004","journal-title":"N Engl J Med"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870305001651?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870305001651?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:15:30Z","timestamp":1757567730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870305001651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0002870305001651"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2005.02.015","relation":{},"ISSN":["0002-8703"],"issn-type":[{"type":"print","value":"0002-8703"}],"subject":[],"published":{"date-parts":[[2005,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of abciximab and preprocedural glycemic control in diabetic patients undergoing elective coronary stenting","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2005.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}